# FireCyte Therapeutics, Inc. — Form D

FireCyte Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-01. The offering totals $12.0M, of which $5.5M was reported sold. Industry: Other.

## Offering

- Filed: 2022-02-01
- Form: D
- Accession: 0001908231-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $5.5M
- Remaining: $6.5M
- Investors: 3
- Date of first sale: 2022-01-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-431729

## Issuer

- Name: FireCyte Therapeutics, Inc.
- CIK: 0001908231
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 215 FIRST STREET, SUITE 500, CAMBRIDGE, MA, 02142
- Phone: 5083442319

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Meredith E Fisher | Director | Cambridge, MA |
| Ruoxi E Hu | Director | Cambridge, MA |
| Charles E Kunsch | Director | Cambridge, MA |
| William E Yelle | Director | Cambridge, MA |
| William E Yelle | Executive Officer | Cambridge, MA |

## More

- [CIK 1908231 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1908231&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001908231-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.